Network News

19 Aug 2016

Tuberculosis: a promising vaccine candidate

Scientists from the Institut Pasteur Paris led by Roland Brosch and Laleh Majlessi (Unit for Integrated Mycobacterial Pathogenomics), working in collaboration with a team from Italy (Department of Biology, University of Pisa), have published the results of their research into the action mechanisms of a promising experimental tuberculosis (TB) vaccine in the journal PLOS Pathogens. BCG, the only currently approved TB vaccine, has been around for almost a century, but it is only partially effective and the protection it offers fades over time. Given the current emergence of adult TB cases in conjunction with the HIV epidemic and the rise in multidrug-resistant TB strains, the development of a new, more effective vaccine is a global health priority. This research was conducted in connection with the TBVAC2020 European consortium.

CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection, PLoS Pathog. July 28, 2016 DOI : 10.1371/journal.ppat.1005770.

Read the full story on Institut Pasteur website.

18 Aug 2016

Institut Pasteur International Network Symposium - “From basic science to biomarkers & tools in global health”, Paris, November 29-December 2, 2016

A unique international scientific symposium on biomarkers open to all the scientific community

The 2016 edition of the Scientific Symposium of the Institut Pasteur International Network covers every aspects of research including basic, clinical and operational science, necessary to identify, validate and develop new biomarkers in human health.

All scientists, clinicians and public health experts from both communicable and non-communicable diseases fields, belonging or not to the Institut Pasteur International Network are welcome to attend as well as civil society representatives, government & international organizations officials and industrial partners.

Building on the success of the last two editions, the Institut Pasteur International Network is confident that this symposium will again establish a high-level forum for multidisciplinary dialogue and exchanges between all stakeholders involved in Global Health/One Health and thus be an opportunity to create fruitful synergies and promote international collaborations that will source of hope for the world health.

350 scientists from 44 countries are gathering in Paris to focus on and discuss about biomarkers. All the 33 institutes members of the Institut Pasteur Network are represented and introduce the different projects conducted within this network.

Follow the event through the live-tweet coverage by Institut Pasteur: Twitter #SympoRIIP

To visit the official website, please click here or on the poster below.